Wu C - Search Results

1

3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.

Li M, Wu C, Yang Y, Zheng M, Yu S, Wang J, Chen L, Li H. Li M, et al. Among authors: wu c. Cell Oncol (Dordr). 2021 Jun;44(3):541-556. doi: 10.1007/s13402-021-00599-9. Epub 2021 Mar 18. Cell Oncol (Dordr). 2021. PMID: 33735398 Review.

2

Glutaminase inhibitors: a patent review.

Wu C, Chen L, Jin S, Li H. Wu C, et al. Expert Opin Ther Pat. 2018 Nov;28(11):823-835. doi: 10.1080/13543776.2018.1530759. Epub 2018 Oct 11. Expert Opin Ther Pat. 2018. PMID: 30273516 Review.

3

Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis.

Zheng M, Wu C, Yang K, Yang Y, Liu Y, Gao S, Wang Q, Li C, Chen L, Li H. Zheng M, et al. Among authors: wu c. Pharmacol Res. 2021 Feb;164:105367. doi: 10.1016/j.phrs.2020.105367. Epub 2020 Dec 8. Pharmacol Res. 2021. PMID: 33307221

4

New natural inhibitors of hexokinase 2 (HK2): Steroids from Ganoderma sinense.

Bao F, Yang K, Wu C, Gao S, Wang P, Chen L, Li H. Bao F, et al. Among authors: wu c. Fitoterapia. 2018 Mar;125:123-129. doi: 10.1016/j.fitote.2018.01.001. Epub 2018 Jan 4. Fitoterapia. 2018. PMID: 29305912

5

A natural inhibitor of kidney-type glutaminase: a withanolide from Physalis pubescens with potent anti-tumor activity.

Wu C, Zheng M, Gao S, Luan S, Cheng L, Wang L, Li J, Chen L, Li H. Wu C, et al. Oncotarget. 2017 Dec 8;8(69):113516-113530. doi: 10.18632/oncotarget.23058. eCollection 2017 Dec 26. Oncotarget. 2017. PMID: 29371926 Free PMC article.

6

Synthesis of novel andrographolide beckmann rearrangement derivatives and evaluation of their HK2-related anti-inflammatory activities.

Wang W, Wu Y, Yang K, Wu C, Tang R, Li H, Chen L. Wang W, et al. Among authors: wu y, wu c. Eur J Med Chem. 2019 Jul 1;173:282-293. doi: 10.1016/j.ejmech.2019.04.022. Epub 2019 Apr 16. Eur J Med Chem. 2019. PMID: 31009914

7

Structure based discovery of novel hexokinase 2 inhibitors.

Liu Y, Li M, Zhang Y, Wu C, Yang K, Gao S, Zheng M, Li X, Li H, Chen L. Liu Y, et al. Among authors: wu c. Bioorg Chem. 2020 Mar;96:103609. doi: 10.1016/j.bioorg.2020.103609. Epub 2020 Jan 21. Bioorg Chem. 2020. PMID: 32007722

8

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.

Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, Wang Q, Xu Y, Li M, Li X, Zheng M, Chen L, Li H. Wu C, et al. Acta Pharm Sin B. 2020 May;10(5):766-788. doi: 10.1016/j.apsb.2020.02.008. Epub 2020 Feb 27. Acta Pharm Sin B. 2020. PMID: 32292689 Free PMC article.

9

Furin: A Potential Therapeutic Target for COVID-19.

Wu C, Zheng M, Yang Y, Gu X, Yang K, Li M, Liu Y, Zhang Q, Zhang P, Wang Y, Wang Q, Xu Y, Zhou Y, Zhang Y, Chen L, Li H. Wu C, et al. iScience. 2020 Oct 23;23(10):101642. doi: 10.1016/j.isci.2020.101642. Epub 2020 Oct 5. iScience. 2020. PMID: 33043282 Free PMC article.

10

Novel PROTACs for degradation of SHP2 protein.

Zheng M, Liu Y, Wu C, Yang K, Wang Q, Zhou Y, Chen L, Li H. Zheng M, et al. Among authors: wu c. Bioorg Chem. 2021 May;110:104788. doi: 10.1016/j.bioorg.2021.104788. Epub 2021 Mar 1. Bioorg Chem. 2021. PMID: 33706076

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,810 results

Search Page

Filters